Novavax (NASDAQ:NVAX) shares soared more than 2,000% last year. But that doesn't mean share performance is over. In this Motley Fool Live video recorded on June 22, 2021, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss catalysts that may lift the shares in the coming months and years.

Olivia Zitkus: I wanted to ask you what you thought about where Novavax is trading right now. It had a crazy 2020, absolutely insane. So far this year, I think it's up more than 60%. Do you think it has more room to grow? What do you think?

Adria Cimino: I think so, I really do. I think that there's a lot more potential. They have orders from various countries, they ramped up the production, infrastructure, and this is just a good way to continue. Now we're on the possibility of revenue ahead, the combined flu and COVID vaccine down the road. These are all things that can lead to share gains. Of course, it might not gain 2,000% in one year like it did last year, but that's OK. I think that still there's potential ahead.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.